Skip to content
OpenCapital
Get started

Precigen PGEN Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2B+82.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$1.98B+18.1%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$6.28B+189%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Enterprise value$2B+234%
P/S72×—

Profitability

See full
Gross margin83.6%—
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Computed from the period-end share price: $1.37B.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's market capitalization?
Precigen (PGEN) reported market capitalization of $1.37B in Q1 2026.
How has Precigen's market capitalization changed year-over-year?
Precigen's market capitalization increased by 212.6% year-over-year, from $438.12M to $1.37B.
What is the long-term trend for Precigen's market capitalization?
Over 5 years (2020 to 2025), Precigen's market capitalization has grown at a -5.6% compound annual growth rate (CAGR), from $1.97B to $1.48B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.